Latest News about NVO
Recent news which mentions NVO
7 Hot Stocks to Book Profits In Before 2023
December 19, 2022
From InvestorPlace
2 Stocks That Could Be Red-Hot Buys in 2023
December 14, 2022
From Motley Fool
From Benzinga
Why Jim Cramer Can't Recommend Investing In Carl Icahn's Company
December 13, 2022
From Benzinga
From Benzinga
After US Launch Bottlenecks, Novo Nordisk Pushes European Rollout For Wegovy In 2023
December 13, 2022
From Benzinga
Our 7 Top Biotech Stock Picks for 2023
December 09, 2022
From InvestorPlace
Stocks That Hit 52-Week Lows On Thursday
December 01, 2022
From Benzinga
3 Healthcare Stocks That Could Set You Up For Life
November 24, 2022
From Motley Fool
Jim Simons 'The Man Who Solved The Market' Sold 3 Healthcare Dividend Payers, But Upped Stake In This One By 153%
November 20, 2022
From Benzinga
Medical Tech Company Concludes Successful Uplist to NYSE American
November 18, 2022
From Benzinga
Why Teva Stock Stumbled Again on Friday
November 04, 2022
From Motley Fool
3 Unstoppable Investments Everyone Needs in Their Portfolio
November 03, 2022
From Motley Fool
United Therapeutics, Super Micro Computer, Novo Nordisk And Other Big Gainers From Wednesday
November 03, 2022
From Benzinga
Novo Nordisk Raises FY22 Earnings Outlook On Robust Ozempic Sales
November 02, 2022
Tickers
NVO
From Benzinga
Novo Nordisk lifts guidance as earnings beat expectations
November 02, 2022
From MarketWatch
The 7 Best Mutual Funds for Your 401(k)
October 18, 2022
From InvestorPlace
Prediction: This Could Be This Company's Next Billion-Dollar Product
October 18, 2022
Tickers
NVO
From Motley Fool
Bankrupt Zosano Sells Its Drug Delivery Tech That Once Partnered With Pharma Giants
October 12, 2022
From Benzinga
From Benzinga
Novo Nordisk Joins NLRP3 Bandwagon, Bets $70M On Ventus' Lead Drug Candidate
September 29, 2022
Tickers
NVO
From Benzinga
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
September 28, 2022
From Benzinga
This Big Pharma Stock Just Got an Upgrade. Is It Time to Buy?
September 27, 2022
From Motley Fool
Novo Nordisk's Experimental Diabetes Treatment Achieves Better Blood Sugar Targets Than Insulin Degludec
September 22, 2022
Tickers
NVO
From Benzinga
Zealand Pharma, Novo Nordisk Ink Licensing Pact For Drug To Lower Blood Sugar Levels
September 07, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.